News and Announcements

Behind the Vapor – Chasing the facts behind e-cigarette health risks

October 22nd, 2014 in Press Release.

Press: October 20, 2014; written by Sara Rimer | BU Research  With the public health community sharply divided over the potential benefit and harm of the popular device—and with conclusive scientific evidence in short supply—the World Health Organization (WHO) released a report in August 2014 that raised serious questions about the health impact... More

Researchers will study relation of environment to breast cancer

October 17th, 2014 in Press Release.

Press: October 16th 2014, written by Todd Feathers | Boston Globe Five eminent Boston researchers will officially join forces Thursday to tackle one of the most perplexing questions about breast cancer: Why do so many people with no family history of the disease get it? The researchers will examine whether common man-made... More

Veracyte to Acquire Allegro Diagnostics: Plans to Launch Lung Cancer Test

September 9th, 2014 in Press Release.

Press release: September 4th 2014  SOUTH SAN FRANCISCO, Calif., Sept. 4, 2014 /PRNewswire/ -- Veracyte, a molecular diagnostics company pioneering the field of molecular cytology, today announced an agreement to acquire Allegro Diagnostics Corp. based in Maynard, Mass., for $21.0 million, comprised of $7.8 million in cash and $13.2 million in Veracyte... More

New way to determine cancer risk of chemicals found

August 25th, 2014 in Press Release, Publications.

Press Release from July 24th 2014 A new study has shown that it is possible to predict long-term cancer risk from a chemical exposure by measuring the short-term effects of that same exposure. The findings, which currently appear in the journal PLOS ONE, will make it possible to develop simpler and cheaper... More

BUSM Researchers Identify Molecule that Could Aid Lung Cancer Detection, Treatment

November 7th, 2013 in Press Release, Publications.

Press Release: From October 28th 2013 Written by Jenny C Leary Researchers at Boston University School of Medicine (BUSM) have discovered a molecule that could help lead to the non-invasive detection of lung cancer as well as its treatment. Using RNA sequencing, the team looked at airway epithelial cells and identified a... More

BUSM Researchers Identify Novel Approach to Study COPD and Treatment Efficacy

May 24th, 2013 in Publications.

Press Release: From April 11, 2013 Written By Jenny C Leary BUSM researchers have pinpointed a genetic signature for chronic obstructive pulmonary disease (COPD) from airway cells harvested utilizing a minimally invasive procedure. The findings provide a novel way to study COPD and could lead to new treatments and... More

Never Smoker Lung Cancer

January 24th, 2013 in Press Release.

Press Release : BU Today January 22 2013 Never Smoked. Lived Right. Died of Lung Cancer. By Rich Barlow Avrum Spira’s aunt died of lung cancer almost 20 years ago. She was a nonsmoking exercise buff in her 40s who hadn’t been exposed to any known toxins; she worked in a government office, More

How gene profiling in emphysema is helping to find a cure

October 12th, 2012 in Publications.

Press Release: BioMed Central August 31, 2012 Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States and is thought to affect almost three million people in the UK. New research published in BioMed Central’s open access journal Genome Medicine has... More

Predictive molecular signature in lymphoma may direct targeted therapy

October 12th, 2012 in Publications.

Press Release: Dana-Farber Cancer Institute September 10, 2012 Researchers from Dana-Farber Cancer Institute, the Broad Institute, Boston University and colleagues have found a molecular "signature" in a common form of lymphoma that identifies patients unlikely to respond to standard chemotherapy, and who might benefit instead from treatment with certain experimental targeted drugs. The... More

Developing tools for early detection of lung cancer

August 3rd, 2012 in Funding.

We are leading a $13.6 million study aimed at developing novel technologies for the early detection of lung cancer. The five-year multi-site, multi-phase study that will focus on active military personnel and veterans is funded by the United States Department of Defense (DOD) Lung Cancer Research... More